Ketoconazole topical - Vyome Biosciences

Drug Profile

Ketoconazole topical - Vyome Biosciences

Alternative Names: Ketoconazole MRT™; VB 7731

Latest Information Update: 14 Jan 2016

Price : $50

At a glance

  • Originator Vyome Biosciences
  • Class Antifungals; Azoles; Piperazines; Small molecules
  • Mechanism of Action 14-alpha demethylase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Mycoses

Highest Development Phases

  • Preclinical Mycoses

Most Recent Events

  • 12 Jan 2016 VB 7731 is available for licensing as of 12 Jan 2016. http://www.vyome.in/
  • 06 Jan 2016 Preclinical trials in Mycoses in India (Topical) (Vyome Biosciences' pipeline, January 2016)
  • 12 Jan 2014 Early research in Mycoses in India (Topical) (Vyome Biosciences' pipeline, January 2016)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top